These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 16142247)
41. Synthesis and biological evaluation of a novel 99mTc(CO)3 complex of ciprofloxacin dithiocarbamate as a potential agent to target infection. Zhang J; Zhang S; Guo H; Wang X Bioorg Med Chem Lett; 2010 Jun; 20(12):3781-4. PubMed ID: 20471828 [TBL] [Abstract][Full Text] [Related]
42. Binding of ciprofloxacin labelled with technetium Tc 99m versus 99mTc-pertechnetate to a live and killed equine isolate of Escherichia coil. Alexander K; Drost WT; Mattoon JS; Kowalski JJ; Funk JA; Crabtree AC Can J Vet Res; 2005 Oct; 69(4):272-7. PubMed ID: 16479725 [TBL] [Abstract][Full Text] [Related]
43. Clinically proven radiopharmaceuticals for infection imaging: mechanisms and applications. Goldsmith SJ; Vallabhajosula S Semin Nucl Med; 2009 Jan; 39(1):2-10. PubMed ID: 19038596 [TBL] [Abstract][Full Text] [Related]
44. Labeling of antibiotics for infection diagnosis. Benitez A; Roca M; Martin-Comin J Q J Nucl Med Mol Imaging; 2006 Jun; 50(2):147-52. PubMed ID: 16770305 [TBL] [Abstract][Full Text] [Related]
45. Re: synthesis and comparison of 99mTc-enrofloxacin and 99mTc-ciprofloxacin. Tewson TJ J Nucl Med; 2005 Jun; 46(6):1077. PubMed ID: 15937322 [No Abstract] [Full Text] [Related]
48. Imaging seminal vesiculitis with Tc-99m ciprofloxacin. Choe W; Kan Ryu J; Kim WH; Chung MH; Suh JK Clin Nucl Med; 2003 Jun; 28(6):501-2. PubMed ID: 12917536 [No Abstract] [Full Text] [Related]
49. Comparative evaluation of 99mTc-depreotide and 201Tl chloride single photon emission tomography in the characterization of pulmonary lesions. Boundas D; Karatzas N; Moralidis E; Arsos G; Drevelengas A; Pistevou-Gompaki K; Karakatsanis C Nucl Med Commun; 2007 Jul; 28(7):533-40. PubMed ID: 17538394 [TBL] [Abstract][Full Text] [Related]
50. The value of FDG-PET in the follow-up of differentiated thyroid cancer: a review of the literature. Stokkel MP; Duchateau CS; Dragoiescu C Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):78-87. PubMed ID: 16557207 [TBL] [Abstract][Full Text] [Related]
51. Receptor targeting agents for imaging inflammation/infection: where are we now? Signore A; Chianelli M; D'Alessandria C; Annovazzi A Q J Nucl Med Mol Imaging; 2006 Sep; 50(3):236-42. PubMed ID: 16868537 [TBL] [Abstract][Full Text] [Related]
52. Imaging of infection and inflammation with 99mTc-Fanolesomab. Love C; Tronco GG; Palestro CJ Q J Nucl Med Mol Imaging; 2006 Jun; 50(2):113-20. PubMed ID: 16770301 [TBL] [Abstract][Full Text] [Related]
53. An infected hip prosthesis in a dog diagnosed with a 99mTc-ciprofloxacin (infecton) scan. Peremans K; De Winter F; Janssens L; Dumont F; Van Bree H; Dierckx R Vet Radiol Ultrasound; 2002; 43(2):178-82. PubMed ID: 11954814 [TBL] [Abstract][Full Text] [Related]
54. The role of FDG PET in the management of lymphoma: practical guidelines. Kirby AM; George Mikhaeel N Nucl Med Commun; 2007 May; 28(5):355-7. PubMed ID: 17414884 [TBL] [Abstract][Full Text] [Related]
55. Clinical acceptance of a molecular imaging agent: a long march with [99mTc]TRODAT. Kung HF; Kung MP; Wey SP; Lin KJ; Yen TC Nucl Med Biol; 2007 Oct; 34(7):787-9. PubMed ID: 17921030 [TBL] [Abstract][Full Text] [Related]